Xencor: 4Q Earnings Snapshot

MONROVIA, Calif. (AP) _ Xencor Inc. (XNCR) on Tuesday reported a loss of $13.7 million in its fourth quarter.

On a per-share basis, the Monrovia, California-based company said it had a loss of 24 cents.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.

The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $41.9 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $21.2 million.

For the year, the company reported a loss of $69.3 million, or $1.21 per share, swinging to a loss in the period. Revenue was reported as $122.7 million.

Xencor shares have increased 11% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $48.35, an increase of 45% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR